Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-02-19 @ 12:11 AM
Study NCT ID:
NCT02429466
Status:
COMPLETED
Last Update Posted:
2020-09-23
First Post:
2015-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
Sponsor:
Nasser Hanna
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-14
First Submit QC Date:
None
Study First Post Date:
2015-04-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-22
Last Update Post Date:
2020-09-23
Last Update Post Date Type:
ACTUAL